Xeno-cannibalism as an exacerbation of self-cannibalism: A possible fruitful survival strategy for cancer cells

Current Pharmaceutical Design

Volumn 14, Issue 3, 2008, Pages 245-252

  Matarrese, P ^a   Ciarlo, L ^a   Tinari, A ^a   Piacentini, M ^b   Malorni, W ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Autophagy; Cancer; Cell death; Huntington disease; Lymphoblastoid cells; Metastasis; Self cannibalism; Xeno cannibalism

Indexed keywords

ASPARTIC PROTEINASE; CATHEPSIN; CHLOROQUINE; CYSTEINE PROTEINASE; CYTOSKELETON PROTEIN; EZRIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; RHO KINASE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

AUTOPHAGY; CANCER CELL; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CYTOSKELETON; EPSTEIN BARR VIRUS; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUNTINGTON CHOREA; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; LYMPHOBLASTOID CELL; METASTASIS; NEOPLASM; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; RNA INTERFERENCE; SCANNING ELECTRON MICROSCOPY; SENESCENCE; XENO AUTOPHAGY; BIOLOGICAL MODEL; CELL AGING; CELL VACUOLE; CYTOLOGY; DRUG DELIVERY SYSTEM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

AUTOPHAGY; CELL AGING; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNE SYSTEM; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; VACUOLES;

EID: 39749191328     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208783413239     Document Type: Review

References (80)

1. Clayers JP, Havarstein LS. Cannabilism and fratricide: Mechanisms and raisons d'etre. Nat Rev Microbiol 2007; 5: 219-29.
2. Marin - Padilla M. Erytrophagocytosis by epithelial cells of a breast carcinoma. Cancer 1977; 39: 1095-9.
3. Tan BH, Meinken C, Bastian M, Bruns H, Legaspi A, Ochoa MT, et al. Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. J Immunol 2006; 17: 1864-71.
4. Majai G, Sarang Z, Csomos K, Zahuczky G, Fesus L. PPAR-gamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. Eur J Immunol 2007; 37: 1343-54.
5. Rydell-Tormanen K, Uller L, Erjefalt JS. Neutrophil cannibalism - a back up when the macrophage clearance system is insufficient. Respir Res 2006 14; 7: 143.
6. Gildea LA, Morris RE, Newman SL. Histoplasma capsulatum yeasts are phogocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells. J Immunol 2001; 166: 1049-56.
7. Takahashi M, Kobayashi Y. Cytokine production in association with phagocytosis of apoptotic cells by immature dendritic cells. Cell Imummol 2003; 226: 105-15.
8. Steinhaus KA, Bernstein F, Bocian ME. Importance of accurate diagnosis in counseling for neural tube defects diagnosed prenatally. Clin Genet 1991; 39: 355-61.
9. DeSimone PA, East R, Powell RD. Phagocytic tumor cell activity in oat cell carcinoma of lung. Hum Pathol 1980; 11: 535-9.
10. Kojima S, Sekine H, Fukui I, Ohshima H. Clinical significance of "cannibalism" in urinary cytology of bladder cancer. Acta Cytol 1998; 42: 1365-9.
11. Banerjee SS, Harris, M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology, 2000; 36: 387-402.
12. Yorimitsu T, Klionsky DJ. Autophagy: Molecular machinery for self-eating. Cell Death Differ 20051; 12: 1542-52.
13. Tinari A, Garofalo T, Sorice M, Esposti MD, Malorni W. Mitoptosis: different pathways for mitochondrial execution. Autophagy 2007; 3: 282-4.
14. Kuroda N, Yamasaki I, Nakayama H, Tamura K, Yamamoto Y, Miyakazi E, et al. Prostatic signet-ring, cell carcinoma: Case report and literature rewiew. Pathol Int 1999; 49: 457-61.
15. Hong JS. The exfoliative cytology of endometrial stromal sarcoma in peritoneal fluid. Acta Cytol 1981; 25: 277-81.
16. Craig ID, Desrosiers P, Lefcoe MS. Giant cell carcinoma of lung. A cytologic study. Acta Cytol 1983; 27: 293-8.
17. Uei, Y, Watanabe Y, Hirota T, Yamamoto H, Watanabe H. Cytologic diagnosis of breast carcinoma with nipple discharge. Acta Cytol 1980; 24: 522-8.
18. Abodief WT, Dey P, Al-Hattab O. Cell cannibalism in ductal carcinoma of breast. Cytopathology 2006; 17: 304-5.
19. Tsang WY, Chan JK, Tang SK, Tse CC, Cheung MM. Large cell lymphoma with fibriflary matrix. Histopathology 1992; 20: 80-2.
20. Gupta K, Dey P. Cell cannibalism: Diagnostic marker of malignancy. Diagn Cytopathol 2003; 28: 86-7.
21. Lugini L, Lozupone F, Matarrese P, Funaro C, Luciani F, Malomi W, et al. Potent phargocytic activity discriminates metastatic and primary human malignant melanomas: A key role of ezrin. Lab Invest 2003; 8: 1555-67.
22. Malomi W, Matarrese P, Tinari A, Farrace MG, Piacentini M. Xeno-cannibalism: A survival "escamotage". Autophagy 2007; 3: 75-7.
23. Montcourrier P, Mangeat PH, Valembois C, Salazar G, Sahuquet A, Daperray C, et al. Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J Cell Sci 1994; 107: 2381-91.
24. Coopman PJ, Do MT, Thompson EW, Mueller SC. Phagocytosis of cross-linked gelatine matrix by human breast carcinoma cells correlates with their invasive capacity. Clin Cancer Res 1998; 4: 507-15.
25. Lugini L, Matarrese P, Tinari A, Lozupone F, Federici C, Iessi E, et al. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. Cancer Res 2006; 66: 3629-38.
26. Ishii Y, Kokai Y, Yamaguchi A, Tsubota H, Kiruchi K. Surface marker expression ofhuman B-cell lymphomas. AIDS Res 1986; 2: 87-93.
27. Inagaki S, Shiotani Y, Yamano M, Shiosaka S, Takagi H, Tateishi K, et al. Distribution, origin, and fine structures of cholecystokinin-8-like immunoreactive terminals in the nucleus ventromedialis hypothalami of the rat. J Neurosci 1984; 4: 1289-99.
28. Kumar PV, Hosseinzadeh M, Bedayat GR. Cytologic findings of medulloblastoma in crash smears. Acta Cytol 2001; 45: 542-6.
29. Getto P, Diekmann O, De Roos AM. On the (dis) advantages of cannibalism. J Math Biol 2005; 51: 695-712.
30. Brouwer M, de Ley L, Feltcamp CA, Elema J, Jongsma AP. Serum dependent cannibalism and autodestruction in cultures of human small cell carcinoma of lung. Cancer Res 1984; 44: 2947-51.
31. Caruso RA, Muda AO, Bersiga A, Rigoli L, Inferrera C. Morphological evidence of neutrophil-tumor cell phagocytosis (cannibalism) in human gastric adenocarcinomas. Ultrastruct Pathol 2002; 26: 315-21.
32. Monteaugudo A, Heller D, Husami N, Levine RU, McCaffrey R, Timor-Tritsch IE. Ovarian steroid cell tumors: Sonographic characteristics. Ultrasound Obstet Gynecol 1997; 10: 282-8.
33. Falini B, Bucciarelli E, Grignani F, Martelli MF. Erythrophagocytosis by undifferentiated lung carcinoma cells. Cancer 1980; 46: 1140-5.
34. Lum JJ, Bauer DE, Kong M, Harris ME, Li C, Lindsten T, et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005; 120: 237-48.
35. Mormone E, Matarrese P, Tinari A, Cannella M, Maglione V, Farrace MG, et al. Genotype dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington's disease. J Neurochem 2006; 98: 1090-9.
36. Chuyang Y, Jo SL, Csernus B, Ilyjek E, Liu Y, Chadburn A, et al. Activation of peroxisome proliferator-activated receptor γ contributes to the survival of T lymphoma cells by affecting cellular metabolism. Amer J Pathol 2007; 170: 722-32.
37. Sabarsky P, Hill RP. The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis 2003; 20: 237-50.
38. Gatenby RA, Gawlinski ET, Gmitro AF, Kaylor B, Gillies RJ. Acid-mediated tumor invasion: A multidisciplinary study, Cancer Res 2006; 66: 5216-23.
39. Rofstated EK, Mathiesen B, Kindem K, Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 2006; 66: 6699-707.
40. Duffy MJ. ne role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 1992; 10: 145-55.
41. Van der-Stappen JW, Williams AC, Maciewicz RA, Paraskeva C. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. Int J Cancer 1996; 67: 547-54.
42. Klose A, Wilbrand-Hennes A, Zigrino P, Weber E, Krieg T, Mauch C, et al. Contact of high-invasive, but not low-invasive, melanoma cells to native collagen I induces the release of mature cathepsin B. Int J Cancer 2006; 118: 2735-43.
43. Frohlich E, Schlagenhauff B, Mohrle M, Weber E, Klessen C, Rassner G. Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma. Cancer 2001; 91: 972-82.
44. Garnett TO, Filippova M, Duerksen-Hughes PJ. Bid is cleaved upstream of caspase-8 activation during TRAIL-mediated apoptosis in human osteosarcoma cells. Apoptosis 2007; 13 [Epub ahead of print].
45. Castino R, Bellio N, Nicotra G, Follo C, Trincheri NF, Isidoro C. Cathepsin D-Bax death pathway in oxidative stressed neuroblastoma cells. Free Radic Biol Med 2007; 42: 1305-16.
46. Desai,B, Rogers MJ, Chellaiah MA. Mechanisms of osteopontin and CD44 as metastatic principles in pTouate cancer cells. Mol Cancer. 2007; 6: 18.
47. Fiordalisi JJ, Keller PJ, Cox AD. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res 2006; 66: 3153-61.
48. Hakuma N, Kinoshita I, Shimizu Y, Yamazaki K, Yoshida K, Nishimura M, et al. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells. Cancer Res 2005; 65: 10776-82.
49. Fiorentini C, Matarrese P, Straface E, Falzano L, Donelli G, Boquet P, et al. Rho-dependent cell spreading activated by E.coli cytotoxic necrotizing factor 1 hinders apoptosis in epithelial cells. Cell Death Differ 1998; 5: 921-9.
50. Fiorentini C, Falzano L, Fabbri A, Stringaro A, Logozzi M, Travaglione S, et al. Activation of rho GTPases by cytotoxic necrotizing factor 1 induces macropinocytosis and scavenging activity in epithelial cells. Mol Biol Cell 2001; 12: 2061-73.
51. Erwig LP, McPhilips KA, Wynes MW, Ivetic A, Ridley AJ, Henson PM. Differential regulation of phagosome maturation in macrophages and dendritic cells mediated by Rho GTPases and ezrin-radixin-moesin (ERM) proteins. Proc Natl Acad Sci USA 2006; 103: 12825-30.
52. Hunter KW. Ezrin, a key component in tumor metastasis. Trends Mol Med 2004; 10: 201-4.
53. Tomas EM, Chau TA, Madrenas J. Clustering of a lipid raft-associated pool of ERM proteins at the immunological synapse upon T cell receptor or CD28 ligation. Immunol Lett 2002; 83: 143-7.
54. Malomi W, Giammarioli AM, Garofalo T, Sorice M. Dynamics of lipid raft components during lymphocyte apoptosis: The paradigmatic role of GD3. Apootosis 2007; 12: 941-9.
55. Giammarioli AM, Garofalo T, Sorice M, Misasi R, Gambardella L, Gradini R, et al. GD3 glycosphingolipid contributes to Fas-mediated apoptosis via association with ezrin cytoskeletal protein. FEBS Lett 2001; 506: 45-50.
56. Kim YJ, Sapp E, Cuiffo BG, Sobin L, Yoder J, Kegel KB, et al. Lysosomal proteases are involved in generation of N-terminal huntingtin fragments. Neurobiol Dis 2006; 22: 346-56.
57. Powers WJ, Videen TO, Markham J, McGee-Minnich L, Antenor-Doney JV, Hershey T, et al. Selective defect of in vivo glycolysis in early Huntingtons disease striatum. Proc Natl Acad Sci USA 2007; 104: 2945-9.
58. Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Kraine D. Transcriptional repression of PGC-alpha by mutant-huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 2006; 127: 59-69.
59. Carew JS, Nawrocki ST, Kabue CN, Zhang H, Yang C, Chung L, et al. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor 'SAHA to overcome Bcr- Abl-mediated drug resistance. Blood 2007; 15 [Epub ahead of print]
60. Walls KC, Klocke BJ, Saftig, P, Shibata M, Uchiyama Y, Roth KA, et al. Altered regulation of phosphatidylinositol 3-kinase signaling in cathepsin D-deficient brain. Autophagy 2007; 3: 222-9.
61. Amaravadi RK, Yu D, Lum,JJ, Bui T, Christophorou MA, Evan GI, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007; 117: 326-36.
62. Levine B. Cell biology: Autophagy and cancer. Nature 2007; 446: 745-7
63. Kaasik A, Rikk T, Piirsoo A, Zharkovsky T, Zharkovsky A. Up-regulation of lysosomal cathepsin L and autophagy during neuronal death induced by reduced serum and potassium, Eur J Neurosci 2005; 22: 1023-31.
64. Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH, et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 2005; 102: 13807-12.
65. Bechet D, Tassa A, Taillandier D, Combaret L, Attaix D. Lysosomal proteolysis in skeletal muscle. Int J Biochem Cell Biol 2005; 37: 2098-114.
66. Lamparska-Przybysz M, Gajkowska B, Motyl T. Cathepsins and BID are involved in the molecular switch between apoptosis and autopbagy in breast cancer MCF-7 cells exposed to camptothecin. J Physic Pharmacol 2005; 56: 159-79.
67. Rubinztein DC, Gestwicki JE, Murphy LO, Klionsky DJ. Potential therapeutic applications of autophagy. Nat Rev Drug Discov 2007; 6: 304-12.
68. Zhang B. Rho GDP dissociation inhibitors as potential targets for anticancer treatment. Drug Resist Updat 2006; 9: 134-41.
69. Walker K, Olson MF. Targeting Ras and Rho GTPases as opportunities for cancer therapeutics. Curr Opin Genet Dev 2005; 15: 62-8.
70. Scott RW, Olson MF. LIM kinases: Function, regulation and association with human disease. J Mol Med 2007; Epub ahead of print
71. Fritz G. HMG-CoA reductase inhibitors (statins) as anticancer drugs (review). Int J Oncol 2005; 27: 1401-9.
72. Denoyelle C, Hong L, Vannier JP, Soria J, Soria C. New insights into the actions of bispbosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and independent-effects. Br J Cancer 2003; 88: 1631-40.
73. Lang JY, Chen H, Zhou J, Zhang YZ, Zhang XW, Li MH, et al. Antimetastatic effect of salvacine on human breast cancer MDA. HB-435 orthotopic xenograft is closely related to RHO-dependent pathway. Clin Cancer Res 2005; 11: 3455-64.
74. Besson A, Assoian RK, Roberts JM. Regulation of the cytoskeleton: An oncogenic function for CDK inhibitors? Nat Rev Cancer 2004; 4: 948-55
75. Lan TT, Duran Alonso MB, Van Noorden CJ, Antiprotease therapy in cancer: hot or not? Expert Opin Biol Ther 2006; 6: 257-79.
76. Jedinak A, Maliar T. Inhibitors of proteases as an cancer drugs. Neoplasma 2005; 52: 185-92.
77. Dash C, Kulkarni A, Dunn B, Rao M. Aspartic peptidase inhibitors: implications in drug development. Crit Rev Biochem Mol Biol 2003; 38: 89-119.
78. Bonelli RK Wenning GK. Pharmacological management of Huntington's disease: An evidence-based review. Curr Pharm Des 2006; 12(21): 2701-20.
79. Tadhav S, Egilleton CD, Konstantopoulos K. Mathematical modeling of cell adhesion in shear flow: Application to targeted drug delivery in inflammation and cancer metastasis. Curr Pharm Des 2007; 13(21): 1511-26.
80. Nie DY, Xu , S, Xiao ZC. DNA vaccine and the CNS exonal regeneration. Curr Pharm Des 2007, 13(24): 2500-6.